Market Research Logo

Global High-density Multiplexed Diagnostic Assays Market 2017-2021

Global High-density Multiplexed Diagnostic Assays Market 2017-2021

About High Density Multiplexed Diagnostic Assays

A multiplex assay is a type of assay used in research to simultaneously measure multiple analytes (dozens or more) in a single run/cycle of the assay. It is distinguished from procedures that measure one analyte at a time. The assay is one of the diagnostic procedures performed in the laboratory, pharmacology, molecular biology, and various other medical procedures. Different types of assays are performed for the detection and diagnosis of patient's sample.

Technavio’s analysts forecast the global high density multiplexed diagnostic assays market to grow at a CAGR of 15.01% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global high density multiplexed diagnostic assays market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global High density multiplexed diagnostic assays Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Thermo Fisher Scientific
  • Abbott
  • F. Hoffmann-La Roche
Other prominent vendors
  • Agilent Technologies
  • Bio-Rad Laboratories
  • Erba Diagnostics
  • GOLD STANDARD DIAGNOSTICS
  • Hologic
  • Luminex
  • Randox Laboratories
Market driver
  • Increasing equipment rental agreements
  • For a full, detailed list, view our report
Market challenge
  • High cost of multiplexed diagnostic assay equipment
  • For a full, detailed list, view our report
Market trend
  • Introduction of automated multiplexed PCR assays
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global High-Density Multiplexed Diagnostic Assays Market 2017-2021

Technavio recognizes the following companies as the key players in the global high-density multiplexed diagnostic assays market: Thermo Fisher Scientific, Abbott, and F. Hoffmann-La Roche.

Other Prominent Vendors in the market are: Agilent Technologies, Bio-Rad Laboratories, Erba Diagnostics, GOLD STANDARD DIAGNOSTICS, Hologic, Luminex, and Randox Laboratories.

Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is introduction of automated multiplexed PCR assays. There are automated multiplex systems for simultaneously screening hepatitis B virus, hepatitis C virus, and HIV-1 in blood donations. This helps in reduced hands-on time and elimination of errors with high sensitivity and specificity.”

According to the report, one driver in the market is increasing equipment rental agreements. Most of the instruments such as clinical chemistry analyzers, immunochemistry analyzers, and multiplexed diagnostic equipment used in the IVD market are provided for rental or lease to the end-users. They need to pay for the initial installations and consumables. Leasing the high-cost instruments is an effective and convenient purchasing alternative for the end-users with limited budgets.

Further, the report states that one challenge in the market is high cost of multiplexed diagnostic assay equipment. The rise in prevalence of infectious diseases such HIV/acquired immunodeficiency syndrome (AIDS) and Hepatitis B has led to the increased use of high-density multiplexed diagnostic assays for screening of infectious agents. It helps in shortening the turn-around time, as it is highly sensitive. For example, in the case of detection of HIV, NAT screening reduces the turn-around time from 20 days to six days. It also helps in the detection of the low level of viral DNA or RNA present in the blood.

Companies Mentioned

Thermo Fisher Scientific, Abbott, and F. Hoffmann-La Roche.Other Prominent Vendors in the market are: Agilent Technologies, Bio-Rad Laboratories, Erba Diagnostics, GOLD STANDARD DIAGNOSTICS, Hologic, Luminex, and Randox Laboratories.

  • Executive summary
  • Scope of the report
  • Research Methodology
  • Introduction
    • Market outline
      • Table Various type of multiplex techniques
      • Table Global multiplexed diagnostic assays market segmentation (%)
  • Market landscape
    • Market overview
      • Table Global high-density multiplexed diagnostic assays market 2016-2021: Overview
    • Market size and forecast
      • Table Global high-density multiplexed diagnostic assays market 2016-2021 ($ billions)
      • Table Features and benefits of personalized medicines: Market impact
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by product
    • High-density multiplexed diagnostic assays (500-10,000 plex)
    • Very high-density multiplexed diagnostic assays (>10,000 plex)
    • Market overview
      • Table Global high-density multiplexed diagnostic assays market by product 2016
      • Table Global high-density multiplexed diagnostic assays market 2016-2021 ($ billions)
      • Table Global very high-density multiplexed diagnostic assays market 2016-2021 ($ billions)
  • Market segmentation by end-user
    • Market overview
      • Table Global high-density multiplexed diagnostic assays: Overview
    • Clinical diagnostic laboratories
      • Table Buying criteria and impact assessment: End-users
    • Hospitals and clinics
  • Geographical segmentation
    • Table Global high-density multiplexed diagnostic assays market 2016-2021: Overview
    • High-density multiplexed diagnostic assays market in Americas
      • Table High-density multiplexed diagnostic assays market in Americas 2016-2021: Overview
      • Table High-density multiplexed diagnostic assays market in Americas 2016-2021 ($ billions)
      • Table Americas: Market metrics in various countries
    • High-density multiplexed diagnostic assays market in EMEA
      • Table High-density multiplexed diagnostic assays market in EMEA 2016-2021: Overview
      • Table High-density multiplexed diagnostic assays market in EMEA 2016-2021 ($ billions)
      • Table EMEA: Market metrics in various countries
    • High-density multiplexed diagnostic assays market in APAC
      • Table High-density multiplexed diagnostic assays market in APAC 2016-2021: Overview
      • Table High-density multiplexed diagnostic assays market in APAC 2016-2021 ($ billions)
      • Table APAC: Market metrics in various countries
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table Benefits of leasing instruments
      • Table Application and indications: High-density multiplexed diagnostic assays market 2016-2021
    • Infectious diseases
    • Oncology
    • Autoimmune diseases
    • Cardiac diseases
    • Allergies
    • Other application areas
      • Table Impact assessment of various application areas
    • Market challenges
  • Market trends
    • Introduction of automated multiplexed PCR assays
    • Higher adoption rate of molecular POCT
    • Improved sensitivity for the detection systems
    • Outsourcing from hospitals to reference laboratories
  • Vendor landscape
    • Competitive landscape analysis
      • Table Competitive structure analysis of global high-density multiplexed diagnostic assays market 2016
      • Table Competitive landscape analysis of global high-density multiplexed diagnostic assays market 2016
      • Table Strategic success factors of companies in global high-density multiplexed diagnostic assays market
  • Key vendor analysis
    • Thermo Fisher Scientific
      • Table Thermo Fisher Scientific: Key highlights
      • Table Thermo Fisher Scientific: Strength assessment
      • Table Thermo Fisher Scientific: Strategy assessment
      • Table Thermo Fisher Scientific: Opportunity assessment
    • Abbott
      • Table Abbott: Key highlights
      • Table Abbott: Strength assessment
      • Table Abbott: Strategy assessment
      • Table Abbott: Opportunity assessment
    • F. Hoffmann-La Roche
      • Table F. Hoffmann-La Roche: Key highlights
      • Table F. Hoffmann-La Roche: Strength assessment
      • Table F. Hoffmann-La Roche: Strategy assessment
      • Table F. Hoffmann-La Roche: Opportunity assessment
    • Key companies to watch
      • Table bioMérieux: Company assessment
      • Table Illumina: Company assessment
      • Table Qiagen: Company assessment
    • Other prominent vendors
      • Table Other prominent vendors in global high-density multiplexed diagnostic assays market
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report